This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Caroline Weiser: Innovator in Vitiligo Treatment
Introduction
Caroline Weiser is a notable inventor based in Hattersheim, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of vitiligo. Her innovative work has led to the development of a unique patent that addresses this skin condition.
Latest Patents
Caroline Weiser holds a patent for "Antisense oligonucleotides against tenascin for treating vitiligo." This invention relates to specific, optionally modified oligonucleotides with a length of up to 17 nucleotides. These oligonucleotides correspond to segments of tenascin-coding sequences or can bind to these sequences. The invention also encompasses the production and use of these oligonucleotides, which can specifically inhibit the expression of tenascin and be utilized in the production of medicaments for treating vitiligo. She has 1 patent to her name.
Career Highlights
Caroline Weiser is associated with Aventis Pharma Deutschland GmbH, where she has been able to apply her expertise in developing innovative treatments. Her work has been instrumental in advancing therapeutic options for patients suffering from vitiligo.
Collaborations
Throughout her career, Caroline has collaborated with notable colleagues, including Anuschirwan Peyman and Eugen Uhlmann. These collaborations have further enriched her research and development efforts.
Conclusion
Caroline Weiser's contributions to the field of medicine, particularly in the treatment of vitiligo, highlight her innovative spirit and dedication to improving patient care. Her patent represents a significant advancement in therapeutic options for this condition.